These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15481207)

  • 21. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of neonatal BCG immunization within an acute hospital trust.
    Eastham KM; Wyllie J
    J Public Health Med; 2001 Dec; 23(4):335-8. PubMed ID: 11873898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethnic differences in selective neonatal BCG immunisation: white British children miss out.
    Srinivasan R; Menon L; Stevens P; Campbell I; Alfaham M
    Thorax; 2006 Mar; 61(3):247-9. PubMed ID: 16384882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective or universal neonatal BCG immunization: what policy for a district with a high incidence of tuberculosis?
    Pharoah PD; Watson JM; Sen S
    Public Health; 1996 May; 110(3):179-83. PubMed ID: 8668765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
    Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An audit of BCG immunisation and tuberculin skin testing in Scotland. Scottish BCG Study Group.
    Pell J; Capewell S
    Health Bull (Edinb); 1996 Nov; 54(6):490-4. PubMed ID: 8990615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacillus Calmette-Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956-1974.
    Rousseau MC; Conus F; Kâ K; El-Zein M; Parent MÉ; Menzies D
    Vaccine; 2017 Aug; 35(36):4777-4784. PubMed ID: 28705514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland.
    Teljeur C; Moran PS; Harrington P; Butler K; Corcoran B; O'Donnell J; Usher C; O'Flanagan D; Connolly K; Ryan M
    Pediatr Infect Dis J; 2018 Aug; 37(8):759-767. PubMed ID: 29432385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contemporary status of BCG vaccine in the world and in Serbia].
    Pesut D
    Med Pregl; 2004; 57 Suppl 1():37-40. PubMed ID: 15686220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of Bacille Calmette-Guérin shortage on immunisation practice and policies in Europe - A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey.
    Kontturi A; Santiago B; Tebruegge M; von Both U; Salo E; Ritz N;
    Tuberculosis (Edinb); 2016 Dec; 101():125-129. PubMed ID: 27865381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis.
    Kelly P; McKeown D; Clancy L
    Eur Respir J; 1997 Mar; 10(3):619-23. PubMed ID: 9072995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
    Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
    Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
    Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N
    Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the selective neonatal BCG program.
    Wroe AL; McKeever C; Thackray S; Bhan A
    Public Health Nurs; 2007; 24(1):60-5. PubMed ID: 17214654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCG, TB and the UK.
    Drug Ther Bull; 2002 Oct; 40(10):78-80. PubMed ID: 12434740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.
    Pang Y; Kang W; Zhao A; Liu G; Du W; Xu M; Wang G; Zhao Y; Zheng S
    Vaccine; 2015 Jan; 33(1):209-13. PubMed ID: 25454854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical complications of bacille Calmette-Guérin (BCG) infection in HIV-infected children: time for a change in policy.
    Karpelowsky JS; Alexander AG; Peek SD; Millar AJ; Rode H
    S Afr Med J; 2008 Oct; 98(10):801-4. PubMed ID: 19115758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [BCG and infants with a high risk of tuberculosis: a study of the vaccination rate in Marseille after suspension of the BCG requirement].
    Danvin C; Bosdure E; Brémond V; Rousset-Rouvière C; Loundou DA; Barreau-Baumstark K; Dubus JC
    Arch Pediatr; 2010 Nov; 17(11):1510-5. PubMed ID: 20880674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. European survey of BCG vaccination policies and surveillance in children, 2005.
    Infuso A; Falzon D;
    Euro Surveill; 2006; 11(3):6-11. PubMed ID: 16567882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCG immunisation in England and Wales: a survey of policy and practice in schoolchildren and neonates.
    Joseph CA; Watson JM; Fern KJ
    BMJ; 1992 Aug; 305(6852):495-8. PubMed ID: 1392994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.